MIP Technologies AB (Lund, Sweden) has announced that  it has received funding for a four-year project, including funding for a three-year Ph.D. position. The EU-funded project, Nemopur, has a goal of developing a technique for purifying active pharmaceutical ingredients (APIs) by combining organic solvent nanofiltration with molecularly imprinted polymers. The project focus will be on the removal of contaminant organic compounds from APIs. The company provides products based on molecularly imprinted polymers for analytical, preparative, and process-scale selective separations. Currently, the company develops analytical separation products in areas such as solid-phase extraction and has multiple ongoing custom process-scale projects with several companies.

News

MIP Technologies AB (Lund, Sweden) has announced that it has received funding for a four-year project, including funding for a three-year Ph.D. position.